Increased device thresholds with subsequent improvement status post-systemic therapy in a patient with multiple myeloma
- PMID: 34820265
- PMCID: PMC8602117
- DOI: 10.1016/j.hrcr.2021.05.005
Increased device thresholds with subsequent improvement status post-systemic therapy in a patient with multiple myeloma
Keywords: Cardiac amyloidosis; Chemotherapy; Device failure; Increasing device thresholds; Multiple myeloma.
Figures



Similar articles
-
Primary systemic amyloidosis with delayed progression to multiple myeloma.Cancer. 1998 Apr 15;82(8):1501-5. Cancer. 1998. PMID: 9554527
-
Renal replacement therapy in multiple myeloma and systemic amyloidosis.Ir J Med Sci. 1993 Jun;162(6):213-7. doi: 10.1007/BF02945197. Ir J Med Sci. 1993. PMID: 8407257
-
[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].Vnitr Lek. 2012 Dec;58(12):896-903. Vnitr Lek. 2012. PMID: 23427947 Czech.
-
[Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].Presse Med. 2012 Mar;41(3 Pt 1):276-89. doi: 10.1016/j.lpm.2011.11.008. Epub 2012 Jan 13. Presse Med. 2012. PMID: 22244725 Review. French.
-
Multiple myeloma with primary amyloidosis presenting with digestive symptoms: A case report and literature review.Arab J Gastroenterol. 2020 Mar;21(1):54-58. doi: 10.1016/j.ajg.2020.01.002. Epub 2020 Feb 20. Arab J Gastroenterol. 2020. PMID: 32088163 Review.
Cited by
-
A case report-facing blues in cardiac amyloidosis: no more a zebra.Eur Heart J Case Rep. 2022 Feb 22;6(2):ytac081. doi: 10.1093/ehjcr/ytac081. eCollection 2022 Feb. Eur Heart J Case Rep. 2022. PMID: 35295735 Free PMC article.
-
[Follow-up of the patient with pacemakers: Interrogation and basic programming].Rev Med Inst Mex Seguro Soc. 2023 Nov 6;61(6):809-818. doi: 10.5281/zenodo.10064399. Rev Med Inst Mex Seguro Soc. 2023. PMID: 37995347 Free PMC article. Review. Spanish.
References
-
- Mulpuru S.K., Madhavan M., McLeod C.J., Cha Y.M., Friedman P.A. Cardiac pacemakers: function, troubleshooting, and management: part 1 of a 2-part series. J Am Coll Cardiol. 2017;69:189–210. - PubMed
-
- Dohrmmann M.L., Goldschlager N.F. Myocardial stimulation threshold in patients with cardiac pacemakers: effects of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin. 1985;3:527–537. - PubMed
-
- Maisel W.H., Hauser R.G., Hammill S.C., et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm. 2009;6:869–885. - PubMed
Publication types
LinkOut - more resources
Full Text Sources